US Patent 9051370 Humanized EGFR antibodies
Patent 9051370 was granted and assigned to Glycotope GmbH on June, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+332 characters)
Article
Patent abstract
The present invention pertains to humanized anti-EGFR antibodies having antigen binding properties similar to those of the murine or chimeric anti-EGFR antibody from which they are derived. In particular, the present invention is directed to humanized anti-EGFR antibodies which are useful in the treatment of cancer.
Edits on 28 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Antje Danielczyk0
Steffen Goletz0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09051370 Humanized EGFR antibodies US Patent 9051370 Humanized EGFR antibodies
Infobox
Patent Number
090513700
Patent Number
90513700
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090513700
Date of Patent
June 9, 2015
0Patent Application Number
138147790
Date Filed
August 10, 2011
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09051370 Humanized EGFR antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09051370
Date of patent
June 9, 2015
Patent application number
13814779
Date Filed
August 10, 2011
Patent primary examiner
Find more entities like US Patent 9051370 Humanized EGFR antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
